Insider trade

CEO sold ~$8.64M of TWST shares in the open market

Traded Oct 2, 2026 · Filed Oct 6, 2026

~$8.64M
Approx. value · 46K sh @ $188.88: 567K
Holds after · shares reported: −11.5%
Since filing · from the first close after the filing, $188.67 → $166.97 on Oct 6, S&P 500 +1.2%

Why it stands out

The CEO of Twist Bioscience sold $8.64M of Twist Bioscience shares. The filing references tax withholding.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEO$1M+Pre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$8,638,799

Shares × reported transaction price

Timing vs results

60 days after results of Aug 3, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references tax withholding

Only flagged when a footnote says so; never inferred

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Automatic saleFiled yesterday

Automatic saleFiled yesterday

Automatic saleFiled yesterday